Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)

    Forecasted

    This upcoming NIH and CDC grant supports early-career scientists at US small businesses with funding, entrepreneurial training, and mentoring to help them transition into entrepreneurship.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)

    The NIH will soon offer grants to support early-career scientists at US small businesses, funding both research and entrepreneurial training, with required mentoring for first-time principal investigators.

    HHS-NIH11Forecasted Jan 5, 2027Forecasted

    NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

    Supports U.S. small businesses in bringing scientific innovations to market through feasibility studies and later research and development, with clinical trials optional.

    HHS-NIH11Due Jan 5, 2027$3,000,000

    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

    NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.

    HHS-NIH11Due Feb 16, 2027$275,000

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.

    HHS-NIH11Forecasted Jul 31, 2027Forecasted

    NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)

    NIH funds U.S. small businesses partnering with nonprofit research institutions to commercialize scientific innovations, supporting feasibility studies through later-stage research and development.

    HHS-NIH11Due Jan 5, 2027$3,000,000